Optimized dosing of momelotinib in myelofibrosis through quantitative medicine: a clinical commentary
Historically, dose-finding in oncology drug development has been guided by maximum tolerated dose (MTD) principles, often exposing patients to unnecessary toxicity without achieving additional effi...
Authors
- Meenakshi Srinivasan (ORCID: https://orcid.org/0000-0002-2718-4335)
- Mahshid Azimi
- Catherine Ellis (ORCID: https://orcid.org/0009-0008-7635-7846)
- Georgios Vlasakakis (ORCID: https://orcid.org/0000-0002-7390-9712)
- Jasmine Sahni
- Fernando Carreño
Publication Details
- Journal
- Leukemia & lymphoma/Leukemia and lymphoma
- Published
- 2026-09-11
- DOI
- https://doi.org/10.1080/10428194.2026.2721768
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00